Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00458484 · ClinicalTrials.gov registry record · NA
Radiosurgery in Treating Patients With Kidney Tumors
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00458484 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 31 participants.
The verdict
NCT00458484, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
RATIONALE: Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial studies the side effects and best dose of giving stereotactic radiosurgery and to see how well it works in treating patients with kidney tumors who are poor candidates for surgery.
Interventions
- RADIATION stereotactic radiosurgery
- PROCEDURE Renal Biopsy
- PROCEDURE Serum Blood Markers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2007-02-20 |
| Est. Completion | 2019-09-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00458484
The ClinicalTrials.gov registry entry for NCT00458484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which stereotactic radiosurgery is the first listed.
NCT00458484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00458484 about?
NCT00458484 is a clinical study titled "Radiosurgery in Treating Patients With Kidney Tumors". RATIONALE: Radiosurgery can send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I/II trial studies the side effects and best dose of giving stereotactic radiosurgery and to see how well it works in treating patients with kidney tumors who are poor candidate...
What is the current status of trial NCT00458484?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2007-02-20. Estimated completion is 2019-09-12.
What interventions are being tested in trial NCT00458484?
The interventions under investigation include: stereotactic radiosurgery (RADIATION), Renal Biopsy (PROCEDURE), Serum Blood Markers (PROCEDURE).
Who is sponsoring clinical trial NCT00458484?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.